These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5000561)

  • 1. Quantitative structure--activity relationships in leucomycin and lincomycin antibiotics.
    Martin YC; Lynn KR
    J Med Chem; 1971 Dec; 14(12):1162-6. PubMed ID: 5000561
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

  • 3. Lincomycin. VII. 4'-Depropyl-4'-ethoxylincomycins.
    Magerlein BJ
    J Med Chem; 1967 Nov; 10(6):1161-2. PubMed ID: 6056049
    [No Abstract]   [Full Text] [Related]  

  • 4. Lincomycin. 14. An improved synthesis and resolution of the antimalarial agent, 1'-demethyl-4'-depropyl-4'-(R)- and -(S)-pentylclindamycin hydrochloride (U-24, 729A).
    Magerlein BJ
    J Med Chem; 1972 Dec; 15(12):1255-9. PubMed ID: 4629012
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity of staphylococci to macrolides and lincomycin].
    Yourassowsky E; Prudhomme MR; Hawotte M
    Acta Clin Belg; 1968; 23(5):304-9. PubMed ID: 5737969
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lincomycin--a new antibiotic].
    Primavesi CA
    Arzneimittelforschung; 1967 Apr; 17(4):500-2. PubMed ID: 4386772
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and bioactivity of lincomycin 2-monoesters.
    Morozowich W; Sinkula AA; MacKellar FA; Lewis C
    J Pharm Sci; 1973 Jul; 62(7):1102-5. PubMed ID: 4714117
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of antibiotics with ribosomes: structure-function relationships and a possible common mechanism for the antibacterial action of the macrolides and lincomycin.
    Wilhelm JM; Oleinick NL; Corcoran JW
    Antimicrob Agents Chemother (Bethesda); 1967; 7():236-50. PubMed ID: 4970204
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on lankacidin-group (T-2636) antibiotics. VII. Structure-activity relationships of lankacidin-group antibiotics.
    Harada S; Yamazaki T; Hatano K; Tsuchiya K; Kishi T
    J Antibiot (Tokyo); 1973 Nov; 26(11):647-57. PubMed ID: 4792112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aspects of the therapeutic action of proteolytic enzymes and antibiotics in experimental staphylococcal infection. The effect of lincomycin, chymotrypsin and their combinations on leukocyte phagocytic activity].
    Berenshteĭn TF; Kardovich GA; Daniushchenkova NM
    Antibiotiki; 1978 Nov; 23(11):1002-5. PubMed ID: 718145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
    Gauze GF; Brazhnikova MG; Shorin VA; Maksimova TS; Ol'khovatova OL; Kudinova MK; Vishniakova IA; Pevzner NS; Shapovalova SP
    Antibiotiki; 1970 Jun; 15(6):483-6. PubMed ID: 4394064
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of erythromycin plus lincomycin association on renal staphylococcia in mice induced by "dissociated resistant" Staphylococcus aureus].
    Bourse R; Daver J; Monnier J
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):750-9. PubMed ID: 5363514
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and bioactivity of lincomycin-7-monoesters.
    Sinkula AA; Morozowich W; Lewis C; MacKellar FA
    J Pharm Sci; 1969 Nov; 58(11):1389-92. PubMed ID: 5349756
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on josamycin. 3. (1) Bacteriological studies. (2) Protective effect against infections due to pathogenic bacteria. (3) Absorption, excretion, distribution in organs and in vivo activities].
    Osono T; Yano K; Mitamoto F; Watanabe S; Ishida H
    Jpn J Antibiot; 1969 Apr; 22(2):159-72. PubMed ID: 4389777
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent developments in lincomycin research.
    Grady JE
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):533-8. PubMed ID: 4388454
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the suppression of protein synthesis and stimulation of RNA synthesis during the action of some antibiotics on Bacillus subtilis mutants].
    Bibikova MV; Gauze GF; Kochetkova GV
    Antibiotiki; 1969 Jun; 14(6):486-9. PubMed ID: 4979790
    [No Abstract]   [Full Text] [Related]  

  • 17. Plaque formation in Bacillus subtilis, and growth inhibition of Bacillus subtilis and Sarcina sp., induced by Schizophyllum commune.
    Parag Y; Parag G
    Can J Microbiol; 1974 Dec; 20(12):1754-7. PubMed ID: 4216400
    [No Abstract]   [Full Text] [Related]  

  • 18. Lincomycin in hospital practice.
    Duncan IB; Jeans B
    Can Med Assoc J; 1965 Sep; 93(13):685-91. PubMed ID: 5828940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistant phenotype of Bacillus subtilis spontaneous mutants isolated in the presence of puromycin and lincomycin.
    Murata M; Ohno S; Kumano M; Yamane K; Ohki R
    Can J Microbiol; 2003 Feb; 49(2):71-7. PubMed ID: 12718394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lincomycin, clindamycin and their applications.
    Spízek J; Rezanka T
    Appl Microbiol Biotechnol; 2004 May; 64(4):455-64. PubMed ID: 14762701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.